United Kingdom of Great Britain and Northern IrelandTuberculosis profile
Population  2014 64 million
Estimates of TB burden * 2014 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.3 (0.29–0.3) 0.46 (0.45–0.46)
Mortality (HIV+TB only) 0.013 (<0.01–0.024) 0.02 (0.01–0.04)
Prevalence  (includes HIV+TB) 9.6 (3.9–18) 15 (6.1–27)
Incidence  (includes HIV+TB) 7.8 (7.3–8.4) 12 (11–13)
Incidence (HIV+TB only) 0.39 (0.31–0.47) 0.6 (0.49–0.74)
         
Case detection, all forms (%) 84 (79–90)    
Estimates of MDR-TB burden * 2014   New   Retreatment
% of TB cases with MDR-TB 1.2 (0.81–1.7) 3.6 (1.3–7.7)
MDR-TB cases among notified pulmonary
TB cases
43 (29–61) 17 (6–35)
TB case notifications 2014 New ** Relapse
Pulmonary, bacteriologically confirmed 2 672    
Pulmonary, clinically diagnosed 872    
Extrapulmonary 3 078    
       
Total new and relapse 6 622    
Previously treated, excluding relapses 455    
Total cases notified 7 077    
Among 6 622 new and relapse cases:
274 (4%) cases aged under 15 years; male:female ratio: 1.4
Reported cases of RR-/MDR-TB 2014 New Retreatment Total **
Cases tested for RR-/MDR-TB 3 820 209 4 266
Laboratory-confirmed RR-/MDR-TB cases     63
Patients started on MDR-TB treatment ***     60
TB/HIV 2014 Number (%)
TB patients with known HIV status 5 552 (78)
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate and cohort size (%) Cohort
New and relapse cases registered in 2013 (82) 7 293
Previously treated cases, excluding relapse, registered in 2013 (75) 496
HIV-positive TB cases, all types, registered in 2013    
RR-/MDR-TB cases started on second-line treatment in 2012 (54) 78
XDR-TB cases started on second-line treatment in 2012   2
Laboratories 2014  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2015  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
*** Includes patients diagnosed before 2014 and patients who were not laboratory-confirmed as having
RR-/MDR-TB
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2016-05-25 Data: www.who.int/tb/data